ArticleScientific reports2017

Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.

Toshinori Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.